Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.259
-4.18 %
$ 2.59 M
Market Cap
-0.04
P/E
BALANCE SHEET
33.8 M
ASSETS
21.3 M
LIABILITIES
12.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Petros Pharmaceuticals, Inc.
| Current Assets | 20.4 M |
| Cash & Short-Term Investments | 13.3 M |
| Receivables | 2.23 M |
| Other Current Assets | 4.83 M |
| Non-Current Assets | 13.4 M |
| Long-Term Investments | 0 |
| PP&E | 255 K |
| Other Non-Current Assets | 13.2 M |
| Current Liabilities | 10.8 M |
| Accounts Payable | 1.71 M |
| Short-Term Debt | 1.28 M |
| Other Current Liabilities | 7.78 M |
| Non-Current Liabilities | 10.5 M |
| Long-Term Debt | 7 M |
| Other Non-Current Liabilities | 3.55 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 13.3 | 9.4 | 23.8 | 17.1 | 2.1 | 2.8 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.2 | 2.1 | 2.5 | 5.2 | 2.6 | 3.5 |
| Inventory | 1.6 | 1.8 | 0.5 | 0.8 | 2.2 | 6.5 |
| Other Current Assets | 3.2 | 1.3 | 3.1 | 2.9 | 5.1 | 3.0 |
| Total Current Assets | 20.4 | 14.7 | 30.5 | 25.9 | 12.1 | 15.8 |
| PP&E | 0.3 | 0.4 | 0.5 | 0.6 | 69.8 K | 0 |
| Intangible Assets | 9.0 | 12.2 | 25.3 | 32.2 | 38.8 | 44.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 2.4 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 4.2 | 5.1 | 11.0 | 11.1 | 7.4 | 4.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 33.8 | 32.4 | 67.4 | 69.9 | 58.4 | 66.9 |
| LIABILITIES | ||||||
| Accounts Payable | 1.7 | 1.8 | 4.6 | 5.6 | 3.8 | 1.8 |
| Short Term Debt | 1.3 | 1.2 | 0 | 7.2 | 6.8 | 19.3 |
| Other Current Liabilities | 7.8 | 4.0 | 26.4 | 29.1 | 30.5 | 17.5 |
| Total Current Liabilities | 10.8 | 7.1 | 31.0 | 41.9 | 41.1 | 38.5 |
| Long Term Debt | 7.0 | 8.7 | 0.4 | 0 | 7.7 | 27.9 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 1.4 | 2.1 |
| Other Liabilities | 3.6 | 0 | 0.5 | 10.5 | 0.1 | 57.4 K |
| Total Liabilities | 21.3 | 15.7 | 31.8 | 52.4 | 50.3 | 68.6 |
| EQUITY | ||||||
| Common Stock | 298 | 208 | 2.07 K | 971 | 29.1 | 1 |
| Retained Earnings | (98.9) | (90.7) | (70.7) | (61.7) | (41.1) | (1.7) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | (29.1) | 0 |
| Total Equity | 12.5 | 16.7 | 35.5 | 17.5 | 8.0 | (1.7) |
| Total Liabilities and Equity | 33.8 | 32.4 | 67.4 | 69.9 | 58.4 | 66.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 2.2 | 2.1 | 1.1 | 1.0 | 0.2 | 100 K |